STATUS OF IFI INFECTIOUS ANTIBODY REAGENTS

TESTS UNDER FOLLOW-UP WITH POSSIBLE CHANGES IN THE SHORT TERM

Temporarily discontinued test

Effective update from 29/04/2024

CODIGO LIS	DESCRIPCION
2497/2498/4418	IGG,M BARTONELLA HENSELAE AB
225 / 3536 / 1160	IGG,M,A CANDIDA ALBICANS AB
2278 / 3686 / 5581 / 5607	IGG,M,A GIARDIA LAMBLIA AB

   Find the record of the test by clicking here

IgE SPECIFIC ANTIBODIES FOR ZINC (c648), SERUM

Erased Test

Test code: 6293

Mnemonic code: C648

Effective update from 26/04/2024

Erased test due to discontinuation of the reagent manufacturing.

   Find the record of the test by clicking here

INTOLERANCE 2

Temporarily discontinued Test

Test code: 7826
Mnemonic code: INTOL

Effective update from 25/04/2024

Temporary test suspension due to the temporary cessation of service by the supplier

   Find the record of the test by clicking here

Wellness Check

Temporarily Descontinued Test

Test code: 7813
Mnemonic code: NHBA

Effective update from 25/04/2024

Temporary test suspension due to the temporary cessation of service by the supplier

   Find the record of the test by clicking here

Leptospira interrogans IgG antibodies, CSF

Temporarily discontinued Test

Test code: 5450, 5451

Mnemonic code: LEPGLC, LEPMCR

Effective update from 25/04/2024

Temporarily discontinued tests due to discontinuation in reagent supply.

                                        Find the record of the test by clicking here

HLA-B27 genotype, total blood

Description, Method, Result Format and Reference values Modification

Test code: 2909

Mnemonic code: B27

Effective update from 06/05/2024

PREVIOUS

NEW

Description: HLA-B27 genotype, total blood Method: Real-Time PCR Result format:  R1  Result Reference Values: Negative       Technique: DNA extraction from whole blood and subsequent amplification by real-time PCR (commercial CE-IVD method) of the HLA-B*27 gene, associated with seronegative spondyloarthropathies, and a control gene.       Explanatory note: It is present in approximately 7% of Caucasian individuals and in 89% of patients with ankylosing spondylitis. It can also be positive in 42% of patients with juvenile rheumatoid arthritis and in 79% of patients diagnosed with Reiter's syndrome. * Source: PNT, Insert  Version of Test: 12

Description: HLA-B27 GENOTYPE, WHOLE BLOOD Method: Multiplex PCR/Real-Time PCR Result format:  R1  Sample                 R2  Result            Reference Values: Interpretation HLA-B27 variant is found in more than 90% of patients with ankylosing spondylitis (Morbus Bechterew). It is also present in 42% of patients with juvenile rheumatoid arthritis and in 79% of Reiter's syndrome patients. However, it is also found in 8-10% of general population, so having the HLA-B27 gene does not mean that a person suffers or will suffer from ankylosing spondylitis. The disease mainly affects men (3 times more common than women) between the ages of 20 and 40 and it is characterized by inflammation of spine (spondylitis), large joints, fingers and feet, leading to stiffness and pain. Eye inflammation is also characteristic. This report should be evaluated by a specialist in the context of all available clinical and family information in conjunction with other laboratory findings. Genetic counselling is recommended. Test method DNA extraction followed by real-time PCR amplification (CE-IVD commercial method) of  HLA-B*27 gene, associated with Behçet's disease predisposition, and a control gene. Test limitations Variants other than those studied are not analyzed. Normal/polymorphic genomic variation in the patient may interfere with variant detection in the sample. References Caffrey MF et al. (1973) Nature. 242:121 Schlosstein L et al. (1973). N Engl J Med. Agrawal P et al. (2024). Cureus 16(1)         Version of Test: 13

      Find the record of the test by clicking here

LEPTOSPIRA INTERROGANS IgG and IgM ANTIBODIES SERUM

Temporarily discontinued Test

Test code: 3114, 3115, 5218

Mnemonic code: LEPTG, LEPT

Effective update from 25/04/2024

Temporarily discontinued tests due to discontinuation in reagent supply.

   Find the record of the test by clicking here

Cloroquine, serum

Reference values Modification

Test code: 5592

Mnemonic code: CLQUI

Effective update from 06/05/2024

PREVIOUS	NEW
0.01 - 0.4 mg/L       LOD and LOQ: 0.005 mg/L                   Version of Test: 15	0.02 - 0.5 mg/L                                    Version of Test: 16

   Find the record of the test by clicking here

IMPORTANT COMMUNICATION: STATUS OF IFI INFECTIOUS ANTIBODY REAGENTS

 IMPORTANT COMMUNICATION: STATUS OF IFI INFECTIOUS ANTIBODY REAGENTS

Dear colleagues and collaborators, 

We inform you about an important update regarding the availability of certain tests and reagents for the Indirect Immunofluorescence (IFI) technique that we have been performing for the detection of infectious disease antibodies.

Recently, we have experienced changes in our supply chain due to circumstances beyond our control and unfortunately, our official supplier of reagents for the IFI technique has permanently ceased production of the reagents.

As a result, some of the tests we offer will be temporarily unavailable or may experience changes in availability. 

We would like to assure you that we are working diligently to minimize any inconvenience this may cause and are exploring all available options to restore the availability of these tests as soon as possible.

We would therefore like to keep you updated on the current situation arising from this event;

TEMPORARILY ERASED TESTS
TEST CODE	DESCRIPTION	OBSERVATIONS
938/ 2032/4715	RESPIRATORY SYNCYTIAL VIRUS IGG,M ANTIBODIES	Pending results will be issued on time
1009/ 1010/4699	INFLUENZA A VIRUS IGG,M ANTIBODIES	Pending results will be issued on time
2040/ 2041	INFLUENZA B VIRUS IGG,M ANTIBODIES	Pending results will be issued on time
3076	INFLUENZA (A+B) VIRUS IGM ANTIBODIES	Pending results will be issued on time
7670/ 3106/ 3229	BORDETELLA PARAPERTUSSIS IGG,M,A ANTIBODIES	Pending results will be issued on time
2064/ 2065/ 2375	BORDETELLA PERTUSSIS IGG,M,A ANTIBODIES	Pending results cannot be issued in a timely manner until test reactivation, for emergencies contact the laboratory.
TESTS UNDER FOLLOW-UP WITH POSSIBLE CHANGES IN THE SHORT TERM
TEST CODE	DESCRIPTION	OBSERVATIONS
2497/ 2498/4418	BARTONELLA HENSELAE IGG,M ANTIBODIES	Pending results will be issued on time
225/ 3536/ 1160	CANDIDA ALBICANS IGG,M,A ANTIBODIES	Pending results will be issued on time
3114/ 3115	LEPTOSPIRA INTERROGANS IGG,M ANTIBODIES	Pending results will be issued on time
4276/ 4275/ 7662	VARICELA ZOSTER IGG,M,A ANTIBODIES	Pending results will be issued on time
7686/ 7687/ 2095/ 7323/ 7324	EPSTEIN BARR VCA IGG,M,A ANTIBODIES	Pending results will be issued on time
2217/ 2218/ 4222/ 4223	IGG,M ANTIBODIES VIRUS HERPES TIPO 6	Pending results will be issued on time
2397	LEGIONELLA PNEUMOPHILA IGA ANTIBODIES	Pending results will be issued on time
2672/ 2671/ 7684/ 7685	COXSACKIE VIRUS A9 IGG,M ANTIBODIES	Pending results will be issued on time
2048/ 2047/ 7681/ 7682	COXSACKIE VIRUS B16 IGG,M ANTIBODIES	Pending results will be issued on time
2278/ 3686/ 5581/5607	GIARDIA LAMBLIA IGG,M,A ANTIBODIES	Pending results will be issued on time
4711/ 4712/ 4714/ 4713	ADENOVIRUS IGG,M ANTIBODIES	Pending results will be issued on time
7310/ 7309	PARAINFLUENZA 1 IGG,M ANTIBODIES	Pending results will be issued on time
7318/ 7319	PARAINFLUENZA 2 IGG,M ANTIBODIES	Pending results will be issued on time
7320/ 7321	PARAINFLUENZA 3 IGG,M ANTIBODIES	Pending results will be issued on time

We understand that this may raise concerns and want to assure you that we are committed to maintaining the quality and integrity of our products.

We are taking all necessary steps to mitigate any impact on your clinical practice and are available to provide the necessary support during this transition period.

Please do not hesitate to contact us for any further clarification.

Yours sincerely,

MOLECULAR STUDY GENOTYPE MHC-B (LOW RESOLUTION), WHOLE BLOOD

Reference values Modification

Test code: 3867

Mnemonic code: Does not apply

Effective update from 22/04/2024

PREVIOUS	NEW
*This result express typification for       every allele of the correspondient loci.             Susceptibility:       . Beheçet disease (B*51)       . Subacute thyroiditis (B*35)       . Carbamazepine susceptibility (B*15:02)                   Version of Test: 4	*This result express typification for every allele of the correspondient loci.                                                                             Version of Test: 5

   Find the record of the test by clicking here

MOLECULAR STUDY GENOTYPE MHC-A (LOW RESOLUTION), WHOLE BLOOD

Reference values Modification

Test code: 3930

Mnemonic code: Does not apply

Effective update from 22/04/2024

PREVIOUS	NEW
*This result express typification for       every allele of the correspondient loci.             Susceptibility:       . Uveitis type Birdshot(A*29)       . Carbamazepine susceptibility (A*31:01)                   Version of Test: 4	*This result express typification for every allele of the correspondient loci.                                                          Version of Test: 5

   Find the record of the test by clicking here

IgE SPECIFIC ANTIBODIES FOR IODINE (c616)

Erased Test

Test code: 6320
Mnemonic code: C616

Effective update from 22/04/2024

Erased test due to discontinuation of the reagent manufacturing.

   Find the record of the test by clicking here

Rotavirus IgM antibodies, Serum

Discontinued Temporarily Test

Test code: 5100

Mnemonic code: ROTAM

Effective update from 19/04/2024

Temporarily discontinued test due to discontinuation in reagent supply.

   Find the record of the test by clicking here

BORDETELLA PERTUSSIS (WHOOPING COUGH) IgA, IGg and IgM ANTIBODIES, SERUM

Temporarily discontinued Test

Test code: 2375, 2064, 2065

Mnemonic code: BORDA, BORDG, BORDM

Effective update from 19/04/2024

Temporarily discontinued tests due to discontinuation in reagent supply.

   Find the record of the test by clicking here

Salicilyc Acid, Serum

Description, Units and Reference Modification

Test code: 256

Mnemònic code: AASA

Effective update from 29/04/2024

PREVIOUS

NEW

Description: Salicilyc Acid, Serum        Units: µg/mL         Reference Values        THERAPEUTIC LEVEL (Anestesia-Analgesic): 20-100 µg/mL       (Antiinflamatory) : 100-300 µg/mL       TOXIC LEVEL: Greater than 300 µg/mL       * Fuente: PNT, Insert                              Version of Test: 7

Description: ACETYLSALICYLIC ACID, SERUM       Units: mg/L       Reference Values:       Therapeutic range: 20 - 200 mg/L       Toxicity: Greater than 300        *Source: Schulz, A. Schmoldt, H. Andresen-Streichert, S. Iwersen-Bergmann. Revisited: Therapeutic and toxic blood concentrations of more than 1,100 drugs and other xenobiotics. Critical Care 2020                                                Version of Test: 8

   Find the record of the test by clicking here

ANTI POLIOVIRUS ANTIBODIES, SERUM

Temporarily Discontinued Test

Test code: 3178

Mnemonic code: POLIO

Effective update from 15/04/2024

Temporarily discontinued test due to discontinuation in reagent supply.

   Find the record of the test by clicking here

IgE SPECIFIC ANTIBODIES FOR IODINE (c616)

Temporarily Discontinued Test

Test code: 6320

Mnemonic code: C616

Effective update from 15/04/2024

Temporarily discontinued test due to discontinuation in reagent supply.

                         Find the record of the test by clicking here

CANNABIS CONFIRMATION (LC-MS/MS), HAIR

Units and Reference values Modification

Test code: 4384

Mnemonic code: CANNP

Effective update from 22/04/2024

PREVIOUS	NEW
Units: ng/mg       Reference Values:       Cut off values recommended by EDWTS, 2022: 0.05 ng/mg hair             EDWTS: European Workplace Drug Testing Society, 2022)                    Version of Test: 5	Units: pg/mg                              Reference Values:       THC Cut-off value: 60 pg/mg       Version of Test: 6

   Find the record of the test by clicking here